Recombinant Human MYH7 Protein，His

MYH7, also known as beta-myosin heavy chain, is a critical component of the thick filament in cardiac and skeletal muscle cells, playing a crucial role in muscle contraction and function. Mutations in the MYH7 gene are associated with various cardiac diseases, particularly familial hypertrophic cardiomyopathy (FHC), which can lead to heart failure and sudden cardiac death. Research on MYH7 recombinant proteins is essential for understanding the structural and functional implications of these mutations, as well as developing targeted therapies. By producing and characterizing MYH7 recombinant proteins, scientists can investigate the molecular mechanisms underlying muscle contraction and elucidate how specific genetic alterations affect protein stability, assembly, and function. This research not only advances our knowledge of cardiac physiology but also holds potential for innovative therapeutic strategies to manage MYH7-related pathologies. Moreover, the study of MYH7 recombinant proteins can facilitate drug screening processes and aid in the development of precision medicine approaches for patients with hereditary cardiovascular disorders. As such, the exploration of MYH7 protein dynamics remains a vital area of investigation in both basic research and clinical applications.